Target
MAP kinase-activated protein kinase 2
Ligand
BDBM50395279
Substrate
n/a
Meas. Tech.
ChEMBL_860552 (CHEMBL2167126)
IC50
1600±n/a nM
Citation
 Kosugi, TMitchell, DRFujino, AImai, MKambe, MKobayashi, SMakino, HMatsueda, YOue, YKomatsu, KImaizumi, KSakai, YSugiura, STakenouchi, OUnoki, GYamakoshi, YCunliffe, VFrearson, JGordon, RHarris, CJKalloo-Hosein, HLe, JPatel, GSimpson, DJSherborne, BThomas, PSSuzuki, NTakimoto-Kamimura, MKataoka, K Mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) as an antiinflammatory target: discovery and in vivo activity of selective pyrazolo[1,5-a]pyrimidine inhibitors using a focused library and structure-based optimization approach. J Med Chem 55:6700-15 (2012) [PubMed]  Article 
Target
Name:
MAP kinase-activated protein kinase 2
Synonyms:
MAP kinase-activated protein kinase 2 (MAPKAPK2) | MAP kinase-activated protein kinase 2 (MK2) | MAP kinase-activated protein kinase 2 (p38/MK2) | MAPK-Activated Protein Kinase 2 (MK2) | MAPK-activated protein kinase 2 | MAPK2_HUMAN | MAPKAP kinase 2 | MAPKAPK-2 | MAPKAPK2 | MK2
Type:
Serine/threonine-protein kinase
Mol. Mass.:
45579.87
Organism:
Homo sapiens (Human)
Description:
P49137
Residue:
400
Sequence:
MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH
  
Inhibitor
Name:
BDBM50395279
Synonyms:
CHEMBL2163991
Type:
Small organic molecule
Emp. Form.:
C24H24ClFN6
Mol. Mass.:
450.939
SMILES:
N[C@H]1CC[C@@H](CC1)Nc1nc2ccnn2c(Nc2ccc(F)c(Cl)c2)c1-c1ccccc1 |r,wU:4.7,wD:1.0,(9.17,-48.98,;9.17,-47.44,;10.51,-46.67,;10.51,-45.12,;9.18,-44.36,;7.84,-45.13,;7.84,-46.67,;9.17,-42.82,;7.84,-42.06,;6.51,-42.82,;5.18,-42.06,;3.71,-42.53,;2.8,-41.28,;3.71,-40.03,;5.18,-40.51,;6.51,-39.74,;6.52,-38.2,;5.19,-37.42,;5.2,-35.89,;3.87,-35.11,;2.53,-35.88,;1.2,-35.11,;2.53,-37.43,;1.2,-38.2,;3.86,-38.19,;7.84,-40.52,;9.18,-39.75,;10.5,-40.53,;11.84,-39.77,;11.84,-38.22,;10.5,-37.45,;9.17,-38.22,)|
Structure:
Search PDB for entries with ligand similarity: